Celixir company

The team of world-class scientists and biotechnology leadership is devoted to discovering breakthrough medicines that change the standard of medical care for patients. Sir Martin Evans, Nobel Laureate, and Ajan Reginald, former Global Head of Emerging Technologies at Roche, originally founded the company under the name Cell Therapy Ltd (CTL) in 2009 which was rebranded as Celixir in 2016.
Technology: P4 Medicine
Industry: Regenerative Medicine
Headquarters: Cardiff, Cardiff, United Kingdom
Founded Date: Undisclosed
Employees Number: 11-50
Funding Status: M&A
Investors Number: 1
Total Funding: $2.6M
Last Funding Type: Venture - Series Unknown

Visit Website
Register and Claim Ownership